Winter Allergies Are Almost Here
December 6, 2024 | Black & Kletz Allergy
Prevention of Peanut Allergy
November 22, 2024 | Black & Kletz Allergy
Much of the information from the past decade regarding when to introduce peanuts into the diet of infants has been reviewed recently and subsequently revised. Research over the past 9 years shows that early introduction and regular consumption of peanuts decreases the risk of developing a peanut allergy. It is no longer recommended that parents delay the introduction of peanuts in most children, as delay beyond 12 months may actually increase the risk of peanut allergy. A landmark clinical trial published in 2015, called the Learning Early About Peanut Allergy (LEAP), showed that the introduction of peanut products into the diets of infants at high risk of developing peanut allergy was safe. This led to an 81% reduction in the subsequent development of the peanut allergy. Prior to 2008, clinical practice guidelines recommended avoidance of potentially allergenic foods in the diets of young children who were at heightened risk for the development of food allergies. The LEAP study was the first to show that the early introduction of dietary peanut is actually beneficial. An extension of the LEAP study published in 2016 called the Learning Early About Peanut Allergy – On (LEAP-On) demonstrated that regular consumption of peanut-containing foods beginning in infancy induces peanut tolerance that persists following a year of avoidance. This suggests that there are lasting benefits of early-life consumption for infants at high risk for developing peanut allergy. Investigators found that most children from the original peanut-consumption group remained protected from peanut allergy at age 6. A new study called the Learning Early About Peanut Allergy – Trio (LEAP-Trio), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), and published in the journal NEJM Evidence on May 28, 2024, further revealed that feeding children peanut products regularly from infancy to age 5 years of age reduced the rate of peanut allergy in adolescence by 71%, even when the children ate or avoided peanut products as desired for many years. The LEAP investigators designed the LEAP-Trio study in order to test whether the protection gained from early consumption of peanut products would last into adolescence if the children could choose to eat peanut products in whatever amount and frequency they desired. The study team enrolled 508 of the original 640 LEAP trial participants—nearly 80%—into the LEAP-Trio study. 255 participants had been in the LEAP peanut-consumption group and 253 had been in the LEAP peanut-avoidance group. The adolescents were assessed for peanut allergy primarily through an oral food challenge. This oral food challenge involved giving participants gradually increasing amounts of peanut in a carefully controlled setting to determine if they could safely consume at least 5 grams of peanut, the equivalent of more than 20 peanuts. The study found that 15.4% of the participants from the early childhood peanut-avoidance group and 4.4% of the individuals from the early childhood peanut-consumption group had peanut allergy at age 12 or older. These results showed that regular, early peanut consumption reduced the risk of peanut allergy in adolescence by 71% compared to early peanut avoidance. The study team also discovered that although participants in the LEAP peanut-consumption group ate more peanut products throughout childhood than the other participants overall, the frequency and amount of peanut consumed varied widely in both groups and included periods of not eating peanut products. This demonstrated that the protective effect of early peanut consumption lasted without the need to eat peanut products consistently throughout childhood and early adolescence. These results confirm that feeding young children peanut products beginning in infancy can provide lasting protection from peanut allergy and further reinforce the current guidelines about the benefits of the early introduction of peanut products. Despite the research about the early introduction of peanuts in infants, it is very important that every parent or guardian discuss this with their infant’s pediatrician before introducing peanuts to their child. Parents and guardians should follow their pediatrician’s recommendation and also seek care from a board certified allergist for an allergy consultation. The board certified allergy specialists at Black & Kletz Allergy have been diagnosing and treating food allergies for more than 50 years. We treat both adult and pediatric patients. Black & Kletz Allergy has offices in Washington, DC, McLean, VA (Tysons Corner, VA), and Manassas, VA. All 3 of our offices have on-site parking. For further convenience, our Washington, DC and McLean, VA offices are Metro accessible. Our McLean office location offers a complementary shuttle that runs between our office and the Spring Hill metro station on the silver line. For an appointment, please call our office or alternatively, you can click Request an Appointment and we will respond within 24 hours by the next business day. If you suffer from food allergies, we are here to help you sort out whether or not you actually have an allergy vs. a food sensitivity. Our allergists will educate you on what to look for and what to do going forward regarding your specific food allergies. Black & Kletz Allergy is dedicated to providing the highest quality allergy care in a relaxed, considerate, and professional environment.Mast Cell Activation Syndrome (MCAS)
November 19, 2024 | Black & Kletz Allergy
Mast cell activation syndrome (MCAS) has been a hot topic in recent years. It seems as though the prevalence is increasing over the last decade. Mast cell activation syndrome is caused by episodes of the abnormal release of mast cell mediators which can affect any organ system, but tends to involve the skin, nervous system, cardiovascular system, and gastrointestinal tract mostly. Before delving into the syndrome, it is important to understand the science behind it. Mast cells are types of white blood cells that generally are found in the connective tissues. There are granules inside the mast cells that contain chemical mediators such as histamine, heparin, tryptase, prostaglandins, leukotrienes, serotonin, and cytokines. Many of these mediators are inflammatory in nature. In addition, mast cells have the allergy antibody, known as IgE, attached to their surfaces. Mast cells play an important role in initiating and promoting immune responses to pathogens (i.e., bacteria, viruses) and toxins (i.e., mold, flying insect stings) by releasing these chemical mediators Mast cells are also responsible for immediate allergic reactions. In an allergic reaction, the IgE on the surface of the mast cells bind to the proteins (i.e., allergens) that cause allergies. The mast cell is now activated, which causes the granules and their contents to be extruded from the mast cells into the tissues in a process called degranulation. As a result, the chemical mediators, which include histamine and chemicals that cause inflammation, are released into the tissues. These chemicals cause the typical symptoms that are generally associated with allergies such as anaphylaxis, itchiness (i.e., pruritus), hives (i.e., urticaria), flushing, swelling (i.e., angioedema), nasal congestion, runny nose, wheezing, chest tightness, coughing, shortness of breath, nausea, vomiting, throat tightness, abdominal pain, abdominal bloating, diarrhea, decreased blood pressure, increased heart rate, lightheadedness, and/or headaches. The symptoms an individual with mast cell activation syndrome experiences depends on where the mast cells are degranulating. In general, children are more likely to have dermatologic symptoms whereas adults tend to have symptoms related to other organ systems as well as the skin. The symptoms associated with the skin may include generalized itching, flushing, hives and/or swelling. Gastrointestinal symptoms may include abdominal bloating, abdominal pain, throat tightness, nausea, vomiting, and/or diarrhea. A patient may exhibit respiratory problems such as coughing, wheezing, shortness of breath, and/or chest tightness. There may be cardiovascular symptoms such as decreased blood pressure, fainting (syncope), lightheadedness, and/or increased heart rate (i.e., palpitations). Neurological manifestations may cause “brain fog,” fatigue, headaches, sleep disturbances, and/or inability to concentrate. If the bone marrow is involved, fractures, bone pain, and anemia may ensue. The lymphatic system may be involved, thus causing swelling of lymph nodes, spleen, liver, and other organs. There is evidence that mast cell activation can be associated with postural orthostatic tachycardia syndrome (POTS). Postural orthostatic tachycardia syndrome is a condition where one’s pulse rate increases by a substantial amount, usually greater than 30 beats per minute) upon standing or sitting up. There is also evidence that mast cell activation can be associated with connective tissue diseases such as hypermobile type of Ehlers-Danlos syndrome (hEDS). A proportion of individuals with the hypermobile type of Ehlers-Danlos syndrome also have mast cell activation syndrome, leading to the possibility of a link between the 2 conditions. In one study, 66% of patients with both a high heart rate when standing [i.e., postural orthostatic tachycardia syndrome (POTS)] and Ehlers-Danlos syndrome also had symptoms consistent mast cell activation syndrome. Sometimes mast cells become defective and release mediators because of abnormal internal signals. Certain mutations in mast cells can produce populations of identical mast cells (i.e., clones) that overproduce and release more chemical mediators. These abnormal clones can grow uncontrollably and are quite sensitive to mast cell activation. Individuals with this condition are said to have a disorder referred to as mastocytosis. Mastocytosis can be further divided into 2 subgroups: cutaneous mastocytosis and systemic mastocytosis. Cutaneous mastocytosis only affects the skin and is more common in children. It is defined by red or brown itchy lesions on the skin. The most common type of cutaneous mastocytosis is called urticaria pigmentosa. Systemic mastocytosis affects other parts of the body besides the skin such as lymph nodes, bone marrow, stomach, intestines, liver, and spleen. Very rarely however, mast cell leukemia or mast cell sarcoma can occur in patients with systemic mastocytosis. The diagnosis of mast cell activation syndrome is somewhat difficult in many patients. Increases in the chemical mediator tryptase may be found in the blood, but normal levels of tryptase does not rule out the diagnosis. Tryptase should be drawn between 30 minutes and 2 hours after the beginning of an episode, with a baseline level obtained many days later. In addition to serum tryptase, elevated 24 hour urine levels of N-methylhistamine, 11B -prostaglandin F2α (11B-PGF2α), and/or leukotriene E4 (LTE4) are useful tests in the diagnosis of mast cell activation syndrome. The treatment of mast cell activation syndrome should aim to relieve the annoying symptoms that many find maddening. H1-blocking antihistamines are effective in reducing many of the symptoms in some individuals. H-2 blockers may work in conjunction with the H1 antihistamines to give better relief. Leukotriene antagonists [i.e., Singulair (montelukast), Accolate (zafirlukast), Zyflo (zileuton) may also offer additional help in alleviating unwanted symptoms. These leukotriene antagonists help by blocking the effects of leukotriene C4 (LTC4) or 5-lipoxygenase (5-LPO), depending on the leukotriene antagonist used. Mast cell stabilizers (i.e., cromolyn sodium) may be useful in that they stabile mast cell membranes, thus reducing degranulation, and causing less of the chemical mediators to be released into the tissues. Aspirin and NSAID’s (nonsteroidal anti-inflammatory agents) have a role in treatment, particularly of flushing, as they block the production of the chemical mediator prostaglandin D2 (PGD2). In recalcitr carry a self-injectable epinephrine device (i.e., EpiPen, Auvi-Q, Adrenaclick)) or Neffy, an epinephrine containing nasal spray, as a precaution. If the epinephrine is used by the patient, the individual should then go to the closest emergency room. Although not FDA-approved to treat mast cell activation syndrome, Xolair (i.e., omalizumab), a monoclonal antibody that blocks the binding of the IgE molecules to its receptors, has been reported to reduce mast cell reactivity and sensitivity to activation which can reduce anaphylactic episodes. The board certified allergy specialists at Black & Kletz Allergy treat both adult and pediatric patients. We have offices in Washington, DC, McLean, VA (Tysons Corner, VA), and Manassas, VA. All 3 of our offices have on-site parking. The Washington, DC and McLean, VA offices are Metro accessible and the McLean, VA office has a free shuttle that runs between our office and the Spring Hill metro station on the silver line. You may also click Request an Appointment and we will respond within 24 hours by the next business day. Black & Kletz Allergy has been a fixture in the greater Washington, DC, Northern Virginia, and Maryland metropolitan community for over 50 years for our outstanding services for the diagnosis and treatment of mast cell activation syndrome, allergic rhinitis (hay fever), asthma, eczema (atopic dermatitis), insect sting allergies, food allergies, medication allergies, hives (urticaria), swelling episodes (angioedema), contact dermatitis, eosinophilic disorders, and immunological conditions.Food Allergies and Halloween
October 18, 2024 | Black & Kletz Allergy
It is that time of the year again. Soon you will be seeing children (and some adults) trick or treating in your neighborhood searching for candy. For children, Halloween is a time to be with their friends, eat a lot of candy, and dress in scary costumes. For millions of parents however, Halloween can also be scary, but for a different reason: Their children have food allergies. According to Food Allergy Research & Education (FARE), approximately 6 million or 1 in 13 children in the U.S. have food allergies. This is about 8% of the U.S. pediatric population which is equivalent to about 2 children per classroom. In addition, more than 26 million adults also have food allergies. Together, there are about 32 million individuals with food allergies in the U.S. which is approximately 10% of the population. What is even more frightening is that the food allergy prevalence among children has increased dramatically within the last 30 years.
To give proper perspective, more than 40% of children with food allergies have experienced a severe allergic reaction to a food such as anaphylaxis. Pediatric hospitalizations for food allergies went up 3-fold in the last 30 years. Every 3 minutes, a reaction to a food causes someone to go to the emergency room, for a total of approximately 200,000 individuals per year requiring emergency care for allergic reactions to a food. Although there are more than 170 foods that have been identified to cause food allergy reactions in the U.S., approximately 90% of all food allergies are caused by the same 8 common foods which include egg, milk, peanuts, soy, wheat, tree nuts, fish, and shellfish. Sesame seeds are becoming more common as well. The most common food allergies in children are peanut, milk, shellfish, and tree nuts. The most common food allergies in adults are shellfish, milk, peanut, and tree nuts. The symptoms that a child (or adult) experiences from a food allergy may include nausea, vomiting, abdominal cramping/pain, diarrhea, swelling (i.e., angioedema) of the lips, throat, tongue, or eyes, hives (i.e., urticaria), shortness of breath, worsening eczema (i.e., atopic dermatitis), generalized itching (i.e., pruritus), wheezing. Of course anaphylaxis is a major concern and all food-allergic children and adults should carry a self-injectable epinephrine device (e.g., EpiPen Jr., EpiPen, Auvi-Q, Adrenaclick) or Neffy, an epinephrine-containing nasal spray. The patient should be instructed to go to the closest emergency room, if they use epinephrine. To help insure that a food-allergic child can take part in Halloween and still have as much fun as a nonallergic child, although nothing is guaranteed, there is a program run by the Food Allergy Research and Education (FARE) organization called the “Teal Pumpkin Project.” This FARE-sponsored international program has been in existence since 2014. The Teal Pumpkin Project began in Tennessee by the mother of a child with severe allergies. The project’s aim is to increase awareness of the severity of food allergies as well as to give support to food-allergic children’s families. In order to participate in the Teal Pumpkin Project, a pumpkin is painted the color teal and then placed on one’s front porch to indicate that “non-food” treats are available at that location on Halloween night. The color teal was chosen because it represents food allergy awareness. Classically, “non-food” treats may include toys, stickers, crayons, necklaces, bracelets, rings, balls, whistles, hair accessories, money, bookmarks, finger puppets, glow sticks, vampire fangs, etc. It is important to mention that the Teal Pumpkin Project is not exclusionary as it still promotes the option of handing out “normal” trick-or-treat candy to children without food allergies. It however recommends that the “non-food” items be placed in a different bowl or box than that a traditional candy bowl. FARE provides a “Teal Pumpkin Project Participation Map” on its website so that participating houses can be easily assessed by the parents of food-allergic children. Whether or not a family or child participates in the Teal Pumpkin Project, reading labels on foods is of the utmost importance. Most families of food-allergic children know how to read labels on foods and avoid those foods that contain ingredients that their children are sensitized to. However, it is important to note that most “fun-sized” candies handed out while trick-or-treating either do not have any labeling at all or they may contain different ingredients than regular sized packages. Children with food allergies should also be instructed to graciously refuse homemade foods such as cupcakes, brownies, and cookies that may be unsafe for them. Preventing children with food allergies to trick-or-treat without adult supervision as well as avoiding candies without proper labeling can prevent a life-threatening reaction. As mentioned above, it is a highly recommended that food-allergic children (and adults) carry a self-injectable epinephrine device (e.g., EpiPen Jr., EpiPen, Auvi-Q, Adrenaclick) or Neffy, an epinephrine-containing nasal spray while trick-or-treating or while eating Halloween candy. The board certified allergists at Black & Kletz Allergy hope that everyone enjoys Halloween. We are here to meet your allergy and asthma needs for the people of the Washington, DC, Northern Virginia, and Maryland metropolitan area. We treat both adults and pediatric patients. We have offices on K Street, N.W. in Washington, DC, McLean, VA (Tysons Corner, VA), and Manassas, VA. There is on-site parking at each of the 3 offices. Our Washington, DC and McLean, VA locations are Metro accessible. Black & Kletz Allergy offers a free shuttle service between our McLean, VA office and the Spring Hill metro station on the silver line. If you suffer from allergies, asthma, sinus problems, hives, or immunological disorders, please call us to make an appointment. You may also click Request an Appointment and we will get back to you within 24 hours by the next business day. Again, we wish you a Halloween.Update on Adult Immunizations
October 15, 2024 | Black & Kletz Allergy
Immunizations are one of the most effective and safe ways of preventing or reducing the risk of serious illness from various infections. Vaccinations also prevent infections from spreading from one individual to another, thus protecting the health and well-being of the general population. One should always check with one’s primary care provider before getting a vaccine. The CDC recommends vaccines for adults based on a variety of factors which may include age, travel destinations, sexual activity, health history, occupation, lifestyle, and previous vaccinations. The CDC currently recommends the following immunizations:
All adults should routinely receive the following vaccines:- Influenza (i.e., flu) vaccine
- Tdap (i.e., tetanus, diphtheria, and whooping cough) or Td vaccine
- COVID-19 vaccine
- Diabetes mellitus (Type 1 & 2), heart disease, lung disease [i.e., asthma, chronic obstructive pulmonary disease (COPD)]: pneumococcal vaccine (see details below)
- Liver disease: hepatitis A, hepatitis B, and pneumococcal vaccines
- End-stage kidney disease: hepatitis B and pneumococcal vaccines
- Weakened immune system excluding HIV infection (i.e., cancer, patients on immunosuppressive medications): Hib [i.e., Haemophilus influenzae type b for individuals with a complement deficiency and for those who have received a hematopoietic stem cell transplant (HSCT, or a bone marrow transplant)], pneumococcal, meningococcal (both MenACWY and MenB for individuals with a complement deficiency), and shingles vaccines
- HIV infection: Vaccine recommendations may differ based on CD4 count. hepatitis A, hepatitis B, meningococcal conjugate vaccine (MenACWY), pneumococcal, and shingles. [If the CD4 count is 200 or greater: In addition to the vaccines listed above, one may also need the chickenpox vaccine (recommended for all adults born in 1980 or later) and the MMR vaccine (recommended for all adults born in 1957 or later)].
- Asplenia (i.e., individuals without a spleen): Hib (i.e., Haemophilus influenzae type b), meningococcal (both MenACWY and MenB), and pneumococcal vaccines
- Pregnancy: Tdap (between 27 and 36 weeks of pregnancy), hepatitis B, influenza, and Covid-19 vaccines. Pregnant women should only receive a vaccination if first approved by their Ob/Gyn physician.
- Chickenpox vaccine: All adults born in 1980 or later
- Hepatitis B vaccine: All adults up to 59 years of age and ages 60 and over with some known risk factors
- HPV (i.e., human papilloma virus) vaccine: All adults until 26 years of age. It is also recommended for selected adults with risk factors from the age of 27 to 45
- MMR vaccine: All adults born in 1957 or later
- Shingles vaccine: All adults 50 years of age and older
- RSV (i.e., respiratory syncytial virus): All adults ages 75 and older and ages 60 to 74 with lung and/or heart disease
- Caused by a bacteria known as Streptococcus pneumoniae
- Mild infections: Ear and sinus infections
- Serious infections: Pneumonia (lung), bacteremia (bloodstream), meningitis (brain and/or spinal cord)
- Conjugate vaccine (PCV15, PCV20, or PCV21): For adults 65 years of age or older and younger than 65 years of age with an increased risk
- Polysaccharide vaccine (PPSV23): For those who received PCV 15 before
Milk Allergy
September 24, 2024 | Black & Kletz Allergy
Milk is one of the most common foods to cause allergic reactions. Almost 3% of children younger than 3 years of age are allergic to milk. Notwithstanding, a vast majority of children spontaneously outgrow their milk sensitivities.
CAUSES: In children with milk allergy, the immune system falsely identifies the protein in the milk as potentially dangerous, and as a result, mounts a defensive attack. The “pre-formed” milk specific antibodies (i.e., immunoglobulin E or IgE) react with the protein in the milk (i.e., antigen), causing release of chemical substances (e.g., histamine, leukotrienes, prostaglandins) into the tissues. These chemical substances are what causes the symptoms of allergic reactions. Cow's milk is the most common cause of milk allergy although milk from sheep and goats can also cause allergic reactions in certain sensitized children. Children are more likely to have a milk allergy if there is a history of a food allergy in other family members. SIGNS and SYMPTOMS: Children usually begin manifesting symptoms of milk allergy within a few minutes after consuming milk products. In some children, however, symptoms can sometimes be delayed for a few hours.- Skin itching, hives, and/or swelling of soft tissues
- Redness, itching, and/or tearing of the eyes
- Fullness/tightness in the throat, difficulty in breathing and/or swallowing
- Nasal congestion, itching, sneezing, and/or clear runny nose
- Abdominal pain, cramping, vomiting, and/or diarrhea
- Irritability, restlessness, and/or dizziness
- Drop in blood pressure, and/or loss of consciousness
- Comprehensive history taking of the milk reaction with focus on the time of exposure to milk, onset time of symptoms, and progression of symptoms.
- Family history of food allergies
- Skin prick testing with a commercially available milk protein antigen with negative and positive controls. If the wheal diameter of the milk protein is more than 3 mm. than that of the negative control, the test is considered positive, signifying the presence of IgE antibodies to milk.
- A blood test can also be utilized to detect and measure the quantities of milk specific IgE antibodies and should be obtained for more severe milk reactions.
- Oral challenge with incremental exposure to milk beginning with a tiny amount and slowly increasing the amount at regular intervals while closely monitoring for signs and symptoms of a reaction. These oral challenges should be undertaken only when trained professionals are readily available to identify and treat possible untoward reactions as soon as they occur.
- Total avoidance of milk and dairy products
- Read labels and identify the ingredients of packaged foods
- In cases of accidental exposures, antihistamines can be given orally or by injection if the symptoms are limited to hives and/or itching of the skin.
- If the symptoms are rapidly progressing and/or in case respiratory, gastro intestinal, and/or cardiac symptoms, epinephrine should be injected into the muscle on an urgent basis. Patients should be prescribed a self-injectable epinephrine device (i.e., EpiPen, Auvi-Q, Adrenaclick) and told to go immediately to the closest emergency room if that device is used.
- Oral immunotherapy is a process of desensitization to milk, which reduces the risk of severe reactions after inadvertent exposure to milk products. This process entails ingestion of small quantities of milk protein in a controlled setting to monitor for reactions. The amount of milk protein will be gradually increased under close medical supervision.
- Xolair (i.e., omalizumab) injections can be given either every 2 or 4 weeks in order to prevent a severe milk allergy, as well as any other food allergy.
- Milk allergy itself may not be preventable, due to a genetic predisposition and susceptibility.
- Diligent avoidance of milk and dairy products such as cream, cheese, butter, ice cream, and yogurt may prevent severe reactions.
- Having a self-injectable epinephrine (e.g., EpiPen, Auvi-Q, Adrenaclick) device readily available at all times can reduce the risks of life-threatening anaphylactic reactions.
Update on Generalized Itching (Pruritus)
September 12, 2024 | Black & Kletz Allergy
Generalized itching (i.e., generalized pruritus) is a condition which can be quite annoying. It is when an individual has diffuse itching of the body usually without an associated rash. Approximately 20-25% of the general population experiences generalized pruritus at least one time in their life. The itching may be intermittent or it may be chronic in nature. “Acute” itching is when the itching has been present for less than 6 weeks. “Chronic” itching is defined by having it for 6 or more weeks. The itching may last for years in certain individuals. The severity of the itching may vary from very mild to very severe where it can interfere with one’s quality of life. If the itching becomes chronic, it is important to see a board certified allergist, like the ones at Black & Kletz Allergy, so that a cause of the itching can hopefully be identified. Note that generalized itching may also be associated with hives (i.e., urticaria) and/or swelling (i.e., angioedema).
There are many causes of generalized itching. Allergies are a very common cause of itching. Allergies to oral and topical medications, foods, cosmetics, fragrances, metals, shampoos, nail polish, latex, poison ivy, poison oak, and poison sumac are just some of the common allergies that may cause itching. Contact dermatitis and eczema, (i.e., atopic dermatitis) are 2 other allergic conditions that may cause itching. Although allergies may be the cause of a lot of individual’s itching, it by no means the only reason for the pruritus. There are a variety of underlying conditions that may cause a person to have itching even though it may not be the most common symptom of the disease. Some of the underlying conditions that can cause itching may include diabetes mellitus, hepatitis B, hepatitis C, kidney disease, thyroid disease, malignancy, iron deficiency anemia, dyshidrotic eczema, HIV, folliculitis, ringworm, seborrheic dermatitis, neurodermatitis, shingles, xerosis (i.e., dry skin), psoriasis, bed bugs, parasitic infections, pregnancy, as well as many others. It is important that a cause be identified so that either the allergen is avoided or the management can be focused on the underlying condition responsible for the itching. The diagnosis of generalized itching begins with a comprehensive history and physical examination. By performing a comprehensive history, the allergist is trying to ascertain the cause of the itching. It is common for a patient to forget or not bring up pertinent information that can help the allergist figure out the cause, so it is important for the allergist to ask a variety of questions in order to try to establish a cause or trigger of the pruritus. Asking questions such as, “Have been on any recent antibiotics or new medications?” or “Do you take aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs)?” are good questions because many patients will not volunteer this information because they do not feel that it is important enough to mention to the physician. In reality, antibiotics, new medications, aspirin, and NSAIDs use are very common reasons for generalized itching. If no obvious allergen can be identified and the itching has lasted 6 weeks or more, looking for an underlying condition is the next step. This is usually done by blood tests. The treatment of generalized itching is directed at avoiding the offending agent. If for example a new medication appears to be causing the itching, the medication should be stopped or changed to another appropriate medication. If it is a certain cosmetic or a specific food, then obviously the cosmetic or food should be avoided. In addition, using oral H1 blockers (i.e., antihistamines) is the most common treatment. Sometimes, adding an H2 blocker and/or a leukotriene antagonist to the Hi blocker is needed. Rarely, oral corticosteroids are needed for severe cases. Topical creams/ointments have been used with limited success. In most cases, medications may only be needed for 1 or 2 weeks, but can be necessary is some individuals for several years. If the itching persists for more than 6 weeks and bloodwork is obtained in order to rule out underlying conditions, then treating the underlying condition may in fact get rid of the itching. The board certified allergy doctors at Black & Kletz Allergy have been diagnosing and treating generalized itching for more than 50 years. We treat both pediatric and adult patients. Black & Kletz Allergy has offices in Washington, DC, McLean, VA (Tysons Corner, VA), and Manassas, VA. All 3 of our offices have on-site parking. For further convenience, our Washington, DC and McLean, VA offices are Metro accessible. Our McLean office location offers a complementary shuttle that runs between our office and the Spring Hill metro station on the silver line. To schedule an appointment, please call our office or alternatively, you can click Request an Appointment and we will respond within 24 hours by the next business day. If you suffer from generalized itching, hives, swelling episodes, or any other allergic condition, the allergy specialists at Black & Kletz Allergy are happy to help you. We are dedicated to providing you with the highest quality allergy care in a relaxed, considerate, and professional environment.New Treatment for Anaphylaxis
August 21, 2024 | Black & Kletz Allergy
Anaphylaxis is an acute, severe, and life-threatening allergic reaction. The most common triggers for anaphylaxis include allergenic foods, medications, and insect stings. Symptoms usually begin within a few minutes of exposure of the triggering agents. Initially, the symptoms characteristically involve the skin which typically causes itching and hives followed by swelling of the soft tissues. Unless treated, the reaction may rapidly progress and may involve other organ systems (e.g., respiratory, gastrointestinal, cardiovascular) resulting in symptoms such as shortness of breath, wheezing, coughing, nausea, vomiting, abdominal pain, dizziness, drop in blood pressure, and/or loss of consciousness. The only effective treatment for anaphylaxis is epinephrine. If given early in the process, it can stop the reaction from progressing and can be life-saving. As anaphylactic reactions can occur after accidental exposures anywhere and at any time, it is recommended to have epinephrine readily available at all times for those at risk for anaphylaxis. Until now, the only form of epinephrine available was an injectable form. The epinephrine is injected into a muscle either with a syringe and a needle or with an autoinjector device. There are a few autoinjectors available in different shapes and sizes and dome of the brand names include EpiPen, Auvi-Q, and Adrenaclick. Autoinjectors are preloaded with different doses of epinephrine suitable for adults and children. One problem with autoinjectors is that some patients and parents of children at risk for anaphylaxis are not comfortable in using them because they are squeamish about needles. As a result, a hesitancy in the use of epinephrine can lead to a delay in administering the needed treatment in a life-threatening situation which can be detrimental. On August 9, 2024, the Food and Drug Administration FDA) approved a new form of epinephrine that is delivered into the nostrils by way of a nasal spray device. It is called Neffy and it uses the same delivery device used to administer other medications into the nasal cavity such as Narcan, a drug useful in reversing the effects of opiates. Neffy delivers 2 mg. of epinephrine into the nasal cavity. (Epipen is available in 0.3mg. and 0.15mg. dosage strengths). In clinical trials, Neffy resulted in comparable blood levels of epinephrine to injectable forms, with a shorter onset of action. It also showed that it can increase the blood pressure and heart rate rapidly, which are indicators for the reversal of the reaction. This nasal epinephrine formulation is approved for adults and children weighing 30 kg. (66 lbs.) and above. Neffy is a single dose nasal spray administered into one nostril. It is available as a 2-pack, which is similar to injectable forms. It is recommended to administer the second dose on Neffy from a different device into the same nostril if the anaphylactic symptoms persist 5 minutes after the initial dose. It is hoped that the nasal spray would remove some barriers for early usage of epinephrine (i.e. the fear of injections) and thus would meet an unmet need. The manufacturer says that most commercially insured patients will pay approximately $25 as copay for a 2-pack, while also offering assistance for patients who are not insured. The medication has a shelf-life of about 30 months and is stable at wide temperature ranges. Neffy was also studied in patients with nasal congestion due to allergies and infections and it was shown to be well absorbed from the nasal cavity without losing its efficacy. Note however that Neffy was not studied in patients with nasal polyps and in patients after nasal surgeries, so its efficacy in these patients is currently unknown. The side effects observed in clinical trial participants included throat irritation, tingling sensation in the nose, runny nose, nasal congestion, headaches, jitteriness, and dizziness. Neffy should also be used with caution in patients with a history of allergic sensitivity to sulfites. Neffy is expected to be available in the pharmacies in October 2024. The board certified allergists at Black & Kletz Allergy see both adult and pediatric patients and have over 5 decades of experience in the field of allergy, asthma, and immunology. Black & Kletz Allergy has 3 convenient locations with on-site parking located in Washington, DC, McLean, VA (Tysons Corner, VA), and Manassas, VA. The Washington, DC and McLean, VA offices are Metro accessible and we offer a free shuttle that runs between the McLean, VA office and the Spring Hill metro station on the silver line. To schedule an appointment, please call any of our offices or you may click Request an Appointment and we will respond within 24 hours by the next business day. We look forward to providing you with the newest cutting edge allergy care in a welcoming and relaxed environment.Ragweed Allergy Update
August 2, 2024 | Black & Kletz Allergy
As the Summer marches on and we are now in the month of August, many allergy sufferers are about to get ready for another foe, namely ragweed. Usually about August 15th of every year, ragweed pollen begins to blanket the Washington, DC, Northern Virginia, and Maryland metropolitan area like clockwork. The dissemination of ragweed pollen generally comes to an end in our region in late October during the first frost. With the rising temperatures and rising carbon dioxide (CO₂) levels, the ragweed season is now longer than it has been historically and it now may begin as early as early August. Ragweed is a flowering plant and considered a weed. Ragweed is widespread in the U.S., particularly in the Midwestern and Eastern and regions of the U.S. Though many weeds (e.g., cocklebur, mugwort/sagebrush, pigweed, Russian thistle) pollinate in the Fall, ragweed is the most common and predominant allergen in our geographical area. The only state without ragweed is Alaska. It is typically found in fields, on the side of roads, in vacant lots, and near riverbanks. There are at least 17 species of ragweed in North America. Even though each ragweed plant lives only 1 season, it can produce approximately 1 billion pollen grains, plenty enough to cause havoc amongst allergy sufferers. Increased humidity in conjunction with warm weather and wind enhances the release of ragweed pollen. The ragweed pollen, like other pollens, is transported by the wind and can travel hundreds of miles due to its light weight. The wind causes the ragweed to become airborne for days which provides an easy way for individuals to become sensitized to the ragweed pollen. The ragweed pollen count is typically lowest in the early morning and it tends to reach its highest in the midday. When a previously sensitized individual has been is exposed to ragweed again in the air, the ragweed proteins trigger specialized cells in the immune system to release increased levels of histamine and other chemical mediators which are responsible for numerous allergic symptoms which is known by the names allergic rhinitis (i.e., hay fever) and/or allergic conjunctivitis (i.e., eye allergies). Some of these symptoms may include runny nose, sneezing, nasal congestion, post-nasal drip, itchy nose, sinus congestion, headaches, itchy throat, fatigue, snoring, itchy eyes, watery eyes, puffy eyes, and/or redness of the eyes. In asthmatics, coughing, chest tightness, wheezing, and/or shortness of breath may also occur. In some ragweed-sensitive individuals, consuming certain fresh fruits or vegetables [e.g., bananas, melons (watermelon, cantaloupe, honeydew), cucumber, zucchini, artichokes, sunflower seeds, white potato, chamomile tea, dandelion] may cause itching and tingling of mouth, tongue, and throat. This condition is called “oral allergy syndrome” or “pollen-food allergy syndrome” and is a result of the cross-reacting proteins in the pollen and fresh fruits or vegetables. The syndrome is caused by allergens in foods that are derived from plants. Thus, only foods that come from plants can cause the syndrome. Ironically, when the fruit or vegetable is canned or cooked, the protein is denatured and destroyed which usually prevents the allergic reaction from happening. Most of the time, individuals can tolerate canned and/or cooked fruits or vegetables. Avoidance is the key to combatting ragweed, if at all possible. Some avoidance measures may include the following:- Keeping the windows and doors at home as well as the windows in automobiles closed and use air-conditioning.
- Decreasing outdoor activities, especially in the early morning hours when the pollen counts tend to be at their highest.
- Showering to remove ragweed pollen from the skin and hair after coming indoors.
- Washing clothes upon returning from outdoors.
- Nasal irrigation can wash the ragweed pollen from the nasal passages.
- Washing the fur and coats of one’s pets after being outside.
Poison Ivy, Poison Oak, and Poison Sumac Summary
July 31, 2024 | Black & Kletz Allergy
Contact dermatitis is an inflammation of the skin triggered by a physical exposure to an allergen. These allergens are usually either chemicals or plants. There are 3 plants, (i.e., poison Ivy, poison oak and poison sumac) which account for a vast majority of plant-based allergens. The active allergen is the sap oil (i.e., urushiol) in the roots, stem, and the leaves of the plants. About half the adult population in the United States develops contact dermatitis after exposure to these plants. Approximately 10 to 50 million people in the U.S. suffer from this condition every year. Certain professions who work outdoors, such as construction workers, farmers, landscapers, and firefighters are at a higher risk to develop plant-induced contact dermatitis than other professions where workers are primarily based indoors. Individuals who have active lifestyles outdoors or who have a hobby or passion that involves the outdoors are also more prone to developing poison Ivy, poison oak and/or poison sumac. On exposure to one of these plants, the sap oil urushiol penetrates the skin and cause inflammation. The uruahiol can also spread to different parts of the body by direct contact. Pets and other animals can also transfer the allergen from the plants to the human skin. In addition, contact with plant-exposed clothing or garden tools can also result in contact dermatitis. Symptoms: The symptoms of poison ivy, poison oak, and/or poison sumac typically begins with a reddish and itchy rash that develops over the exposed area of the skin approximately 1 to 2 days after the exposure. Note that the rash may take up to 2 weeks in some individuals to develop after the first exposure, however, as mentioned above, it typically begins within the first day or two. The rash is usually intensely itchy and may cause a burning sensation in some individuals. In severe cases, fluid-filled blisters may develop and they are usually arranged in linear streaks, a pattern that can be explained by the contact with a branch of leaves touching the skin. The symptoms usually increase in intensity over the next week and the whole episode gradually resolves after 2 to 3 weeks. Management: The whole body should be washed with soap and water as soon as possible after exposure to these plants. The oily urushiol should be removed from everywhere before it has a chance to get absorbed. Clothing and other items that were exposed to the plants should be thoroughly washed as well. It is also prudent to bathe any pet that was exposed. Treatment:- Wet compresses may help to reduce inflammation and pain.
- Soothing agents such as calamine lotion, zinc oxide, and/or oatmeal baths can reduce irritation and discomfort.
- Topical corticosteroid creams/ointments will help control inflammation and can reduce blistering and itching.
- If more than 20% of the body surface area is involved and/or in case of a severe rash over the face, hands, genitals, etc., systemic corticosteroids (e.g. oral prednisone) may be helpful.
- Antihistamines can offer some marginal relief from itching. First generation antihistamines are usually more effective but should not be used when one needs to be fully alert and awake as they may cause drowsiness and fatigue.
- Occasionally, antibiotics are necessary to treat secondary infections that can occur.
- Identifying and avoiding exposure to poison ivy, poison oak, and/or poison sumac is the only definitive way in preventing plant-induced contact dermatitis.
- Wearing long sleeves, long pants, boots, and gloves before gardening and other outdoor activities can reduce direct exposure to the plant oils.
- Barrier skin creams such as Ivy Block or IvyX applied over the skin before possible exposure may offer some additional protection.